Jeffrey W. Albers - Insider Trading & Ownership

Entity
Individual
Location
Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge, Massachusetts
Summary
The estimated net worth of Jeffrey W. Albers is at least $17.6 M dollars as of June 20, 2024. Jeffrey W. Albers is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $17.6 M. Jeffrey W. Albers is the Director of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (AGLE) stock worth about $19.3 K.
All Insider Reports
All Insider Reports

Ownership of Jeffrey W. Albers

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BPMC Blueprint Medicines Corp Director $17.6 M -$10.1 M -36.5% Jun 12, 2024
AGLE Spyre Therapeutics, Inc. Director $19.3 K May 14, 2024
KYMR Kymera Therapeutics, Inc. Director $0 -$496 K -100% Jun 18, 2024
DNTH Dianthus Therapeutics, Inc. /DE/ Director Jun 28, 2022

Insider Transactions Reported by Jeffrey W. Albers:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership